RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,009,945 shares; 2024Q4: 1,213,257 shares; 2025Q1: 1,281,640 shares; 2025Q2: 1,330,960 shares; 2025Q3: 1,335,270 shares; 2025Q4: 1,335,270 shares; 2026Q1: 1,209,465 shares; 2026Q2: 1,105,210 shares 1,105,210 $207M 10.1% -104,255 Timeline TVTX TRAVERE THERAPEUTICS INC More: the full row for TRAVERE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,684,476 shares; 2024Q4: 4,973,649 shares; 2025Q1: 2,921,196 shares; 2025Q2: 1,908,208 shares; 2025Q3: 2,164,773 shares; 2025Q4: 2,210,322 shares; 2026Q1: 1,477,954 shares; 2026Q2: 2,179,069 shares 2,179,069 $124M 6.04% +701,115 Timeline LLY ELI LILLY & CO More: the full row for ELI LILLY & CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 142,000 shares; 2024Q4: 144,500 shares; 2025Q1: 113,500 shares; 2025Q2: 116,500 shares; 2025Q3: 105,400 shares; 2025Q4: 105,400 shares; 2026Q1: 98,700 shares; 2026Q2: 98,700 shares 98,700 $118M 5.78% 0 Timeline MDGL MADRIGAL PHARMACEUTICALS INC More: the full row for MADRIGAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 263,062 shares; 2024Q4: 265,212 shares; 2025Q1: 166,698 shares; 2025Q2: 140,296 shares; 2025Q3: 137,746 shares; 2025Q4: 139,618 shares; 2026Q1: 170,999 shares; 2026Q2: 174,999 shares 174,999 $94M 4.59% +4,000 Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,580,488 shares; 2024Q4: 1,471,564 shares; 2025Q1: 951,765 shares; 2025Q2: 818,206 shares; 2025Q3: 761,126 shares; 2025Q4: 762,294 shares; 2026Q1: 811,294 shares; 2026Q2: 798,145 shares 798,145 $93.4M 4.56% -13,149 Timeline RYTM RHYTHM PHARMACEUTICALS INC More: the full row for RHYTHM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,228,093 shares; 2024Q4: 1,162,718 shares; 2025Q1: 834,188 shares; 2025Q2: 861,153 shares; 2025Q3: 717,102 shares; 2025Q4: 695,010 shares; 2026Q1: 689,748 shares; 2026Q2: 692,598 shares 692,598 $76.9M 3.75% +2,850 Timeline KYMR KYMERA THERAPEUTICS INC More: the full row for KYMERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,049,386 shares; 2024Q4: 1,034,137 shares; 2025Q1: 794,437 shares; 2025Q2: 450,374 shares; 2025Q3: 450,374 shares; 2025Q4: 496,871 shares; 2026Q1: 496,871 shares; 2026Q2: 453,156 shares 453,156 $52M 2.54% -43,715 Timeline ARGX ARGENX SE More: the full row for ARGENX SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 233,500 shares; 2024Q4: 229,600 shares; 2025Q1: 175,750 shares; 2025Q2: 175,750 shares; 2025Q3: 142,750 shares; 2025Q4: 103,250 shares; 2026Q1: 98,500 shares; 2026Q2: 52,750 shares 52,750 $48.9M 2.39% -45,750 Timeline ASND ASCENDIS PHARMA A/S More: the full row for ASCENDIS PHARMA A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 168,750 shares 168,750 $45M 2.2% new Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,316,477 shares; 2024Q4: 1,251,859 shares; 2025Q1: 931,681 shares; 2025Q2: 931,681 shares; 2025Q3: 851,744 shares; 2025Q4: 787,788 shares; 2026Q1: 763,020 shares; 2026Q2: 683,907 shares 683,907 $41.3M 2.01% -79,113 Timeline SRRK SCHOLAR ROCK HLDG CORP More: the full row for SCHOLAR ROCK HLDG CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 716,782 shares; 2025Q1: 761,541 shares; 2025Q2: 794,133 shares; 2025Q3: 794,133 shares; 2025Q4: 733,477 shares; 2026Q1: 739,816 shares; 2026Q2: 715,452 shares 715,452 $39.3M 1.92% -24,364 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 683,344 shares; 2024Q4: 550,000 shares; 2025Q1: 515,900 shares; 2025Q2: 525,000 shares; 2025Q3: 385,000 shares; 2025Q4: 319,250 shares; 2026Q1: 314,300 shares; 2026Q2: 362,150 shares 362,150 $38.6M 1.88% +47,850 Timeline PEN PENUMBRA INC More: the full row for PENUMBRA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 265,000 shares; 2024Q4: 240,000 shares; 2025Q1: 171,000 shares; 2025Q2: 128,500 shares; 2025Q3: 120,500 shares; 2025Q4: 120,500 shares; 2026Q1: 120,500 shares; 2026Q2: 115,750 shares 115,750 $36.5M 1.78% -4,750 Timeline GPCR STRUCTURE THERAPEUTICS INC More: the full row for STRUCTURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,063,910 shares; 2024Q4: 1,080,963 shares; 2025Q1: 1,132,979 shares; 2025Q2: 1,135,879 shares; 2025Q3: 951,154 shares; 2025Q4: 748,236 shares; 2026Q1: 640,217 shares; 2026Q2: 640,317 shares 640,317 $34.4M 1.68% +100 Timeline RARE ULTRAGENYX PHARMACEUTICAL IN More: the full row for ULTRAGENYX PHARMACEUTICAL IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,978,272 shares; 2024Q4: 1,739,813 shares; 2025Q1: 1,394,434 shares; 2025Q2: 1,391,072 shares; 2025Q3: 1,246,341 shares; 2025Q4: 1,267,241 shares; 2026Q1: 1,218,773 shares; 2026Q2: 967,855 shares 967,855 $32.3M 1.58% -250,918 Timeline IRTC IRHYTHM HOLDINGS INC More: the full row for IRHYTHM HOLDINGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 397,500 shares; 2024Q4: 397,500 shares; 2025Q1: 254,300 shares; 2025Q2: 242,500 shares; 2025Q3: 235,000 shares; 2025Q4: 235,000 shares; 2026Q1: 261,750 shares; 2026Q2: 269,650 shares 269,650 $32.1M 1.57% +7,900 Timeline ISRG INTUITIVE SURGICAL INC More: the full row for INTUITIVE SURGICAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 270,000 shares; 2024Q4: 216,000 shares; 2025Q1: 102,000 shares; 2025Q2: 82,000 shares; 2025Q3: 82,000 shares; 2025Q4: 82,000 shares; 2026Q1: 82,000 shares; 2026Q2: 76,460 shares 76,460 $30.4M 1.48% -5,540 Timeline AGL AGILON HEALTH INC More: the full row for AGILON HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 260,000 shares; 2026Q2: 262,600 shares 262,600 $28.1M 1.37% +2,600 Timeline UNH UNITEDHEALTH GROUP INC More: the full row for UNITEDHEALTH GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 294,250 shares; 2024Q4: 176,000 shares; 2025Q1: 100,500 shares; 2025Q2: 50,500 shares; 2025Q3: not reported; 2025Q4: 40,800 shares; 2026Q1: 53,000 shares; 2026Q2: 63,750 shares 63,750 $26.5M 1.29% +10,750 Timeline CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,103,778 shares; 2024Q4: 1,222,182 shares; 2025Q1: 812,653 shares; 2025Q2: 812,653 shares; 2025Q3: 721,538 shares; 2025Q4: 692,538 shares; 2026Q1: 650,270 shares; 2026Q2: 699,146 shares 699,146 $26M 1.27% +48,876 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 951,710 shares; 2026Q1: 1,103,469 shares; 2026Q2: 1,402,150 shares 1,402,150 $25.7M 1.25% +298,681 Timeline NBIX NEUROCRINE BIOSCIENCES INC More: the full row for NEUROCRINE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 939,000 shares; 2024Q4: 720,500 shares; 2025Q1: 279,000 shares; 2025Q2: 88,800 shares; 2025Q3: 89,750 shares; 2025Q4: 125,500 shares; 2026Q1: 150,450 shares; 2026Q2: 144,750 shares 144,750 $24.4M 1.19% -5,700 Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 428,571 shares; 2024Q4: 428,571 shares; 2025Q1: 465,871 shares; 2025Q2: 701,408 shares; 2025Q3: 686,107 shares; 2025Q4: 798,405 shares; 2026Q1: 826,500 shares; 2026Q2: 464,625 shares 464,625 $23.6M 1.15% -361,875 Timeline THC TENET HEALTHCARE CORP More: the full row for TENET HEALTHCARE CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 129,200 shares; 2025Q1: 130,000 shares; 2025Q2: 130,000 shares; 2025Q3: 125,000 shares; 2025Q4: 125,000 shares; 2026Q1: 125,000 shares; 2026Q2: 125,000 shares 125,000 $23.4M 1.14% 0 Timeline DXCM DEXCOM INC More: the full row for DEXCOM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 524,000 shares; 2024Q4: 353,000 shares; 2025Q1: 397,650 shares; 2025Q2: 286,750 shares; 2025Q3: 316,900 shares; 2025Q4: 347,300 shares; 2026Q1: 355,600 shares; 2026Q2: 343,000 shares 343,000 $23.1M 1.13% -12,600 Timeline ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,753,495 shares; 2024Q4: 6,204,309 shares; 2025Q1: 5,046,309 shares; 2025Q2: 4,769,309 shares; 2025Q3: 4,609,309 shares; 2025Q4: 4,453,741 shares; 2026Q1: 4,472,650 shares; 2026Q2: 4,330,532 shares 4,330,532 $22.9M 1.12% -142,118 Timeline MMED MINIMED GROUP INC More: the full row for MINIMED GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,055,000 shares; 2026Q2: 1,520,000 shares 1,520,000 $22.7M 1.11% +465,000 Timeline BSX BOSTON SCIENTIFIC CORP More: the full row for BOSTON SCIENTIFIC CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 460,000 shares; 2024Q4: 460,000 shares; 2025Q1: 277,000 shares; 2025Q2: 355,000 shares; 2025Q3: 360,250 shares; 2025Q4: 399,050 shares; 2026Q1: 515,300 shares; 2026Q2: 528,500 shares 528,500 $22.6M 1.1% +13,200 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 756,931 shares; 2024Q4: 775,131 shares; 2025Q1: 623,402 shares; 2025Q2: 623,402 shares; 2025Q3: 623,402 shares; 2025Q4: 623,402 shares; 2026Q1: 645,533 shares; 2026Q2: 648,333 shares 648,333 $22.4M 1.09% +2,800 Timeline AVLN AVALYN PHARMACEUTICALS INC More: the full row for AVALYN PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 662,918 shares 662,918 $21.8M 1.07% new Timeline COAG HEMAB THERAPEUTICS HLDGS INC More: the full row for HEMAB THERAPEUTICS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 575,432 shares 575,432 $21.1M 1.03% new Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 461,028 shares; 2024Q4: 474,528 shares; 2025Q1: 524,499 shares; 2025Q2: 580,998 shares; 2025Q3: 824,061 shares; 2025Q4: 912,955 shares; 2026Q1: 972,198 shares; 2026Q2: 942,154 shares 942,154 $20.9M 1.02% -30,044 Timeline ALNY ALNYLAM PHARMACEUTICALS INC More: the full row for ALNYLAM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 250,000 shares; 2024Q4: 256,200 shares; 2025Q1: 143,250 shares; 2025Q2: 100,000 shares; 2025Q3: 74,250 shares; 2025Q4: 71,250 shares; 2026Q1: 74,000 shares; 2026Q2: 66,750 shares 66,750 $20.1M 0.98% -7,250 Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 800,199 shares; 2025Q3: 1,008,308 shares; 2025Q4: 849,030 shares; 2026Q1: 624,155 shares; 2026Q2: 515,917 shares 515,917 $20M 0.97% -108,238 Timeline AGIO AGIOS PHARMACEUTICALS INC More: the full row for AGIOS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 699,389 shares; 2024Q4: 471,086 shares; 2025Q1: 342,180 shares; 2025Q2: 989,745 shares; 2025Q3: 958,542 shares; 2025Q4: 799,163 shares; 2026Q1: 799,163 shares; 2026Q2: 532,563 shares 532,563 $19.8M 0.96% -266,600 Timeline NAMS NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 353,319 shares; 2024Q4: 767,522 shares; 2025Q1: 536,111 shares; 2025Q2: 536,111 shares; 2025Q3: 595,929 shares; 2025Q4: 557,194 shares; 2026Q1: 588,794 shares; 2026Q2: 582,744 shares 582,744 $19.7M 0.96% -6,050 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 383,492 shares; 2024Q4: 487,863 shares; 2025Q1: 520,796 shares; 2025Q2: 617,396 shares; 2025Q3: 617,396 shares; 2025Q4: 568,579 shares; 2026Q1: 503,585 shares; 2026Q2: 427,584 shares 427,584 $18.3M 0.9% -76,001 Timeline TARS TARSUS PHARMACEUTICALS INC More: the full row for TARSUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 110,889 shares; 2025Q1: 354,376 shares; 2025Q2: 373,750 shares; 2025Q3: 288,344 shares; 2025Q4: 260,344 shares; 2026Q1: 225,179 shares; 2026Q2: 277,087 shares 277,087 $17.4M 0.85% +51,908 Timeline HTFL HEARTFLOW INC More: the full row for HEARTFLOW INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,000 shares; 2025Q4: 277,700 shares; 2026Q1: 572,500 shares; 2026Q2: 573,500 shares 573,500 $16.8M 0.82% +1,000 Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 282,624 shares; 2025Q4: 282,624 shares; 2026Q1: 287,967 shares; 2026Q2: 298,218 shares 298,218 $16.5M 0.8% +10,251 Timeline CYTK CYTOKINETICS INC More: the full row for CYTOKINETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 206,108 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,853 shares; 2026Q1: 45,364 shares; 2026Q2: 187,980 shares 187,980 $16M 0.78% +142,616 Timeline BCAX BICARA THERAPEUTICS INC More: the full row for BICARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 445,975 shares; 2024Q4: 445,975 shares; 2025Q1: 336,070 shares; 2025Q2: 336,070 shares; 2025Q3: 370,666 shares; 2025Q4: 429,095 shares; 2026Q1: 489,095 shares; 2026Q2: 535,286 shares 535,286 $15.9M 0.78% +46,191 Timeline PBLS PARABILIS MEDICINES INC More: the full row for PARABILIS MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 578,028 shares 578,028 $15.8M 0.77% new Timeline ZLAB ZAI LAB LTD More: the full row for ZAI LAB LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,315,673 shares; 2024Q4: 1,305,337 shares; 2025Q1: 904,592 shares; 2025Q2: 871,392 shares; 2025Q3: 791,193 shares; 2025Q4: 811,546 shares; 2026Q1: 814,707 shares; 2026Q2: 814,707 shares 814,707 $15.5M 0.76% 0 Timeline DHR DANAHER CORP DEL More: the full row for DANAHER CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 58,800 shares; 2025Q2: 59,000 shares; 2025Q3: 61,500 shares; 2025Q4: 61,500 shares; 2026Q1: 61,500 shares; 2026Q2: 76,300 shares 76,300 $14.5M 0.71% +14,800 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 386,915 shares; 2026Q1: 386,915 shares; 2026Q2: 456,551 shares 456,551 $14.3M 0.7% +69,636 Timeline EVH EVOLENT HEALTH INC More: the full row for EVOLENT HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,070,000 shares; 2024Q4: 2,060,000 shares; 2025Q1: 2,695,700 shares; 2025Q2: 2,820,700 shares; 2025Q3: 2,950,000 shares; 2025Q4: 2,675,000 shares; 2026Q1: 2,675,000 shares; 2026Q2: 2,500,000 shares 2,500,000 $13.6M 0.66% -175,000 Timeline PTCT PTC THERAPEUTICS INC More: the full row for PTC THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 61,879 shares; 2026Q1: 161,798 shares; 2026Q2: 162,298 shares 162,298 $13.2M 0.65% +500 Timeline MLYS MINERALYS THERAPEUTICS INC More: the full row for MINERALYS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 320,813 shares; 2025Q2: 324,513 shares; 2025Q3: 408,313 shares; 2025Q4: 427,596 shares; 2026Q1: 439,751 shares; 2026Q2: 484,951 shares 484,951 $13.1M 0.64% +45,200 Timeline ZBIO ZENAS BIOPHARMA INC More: the full row for ZENAS BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 878,667 shares; 2024Q4: 878,667 shares; 2025Q1: 878,667 shares; 2025Q2: 640,467 shares; 2025Q3: 580,677 shares; 2025Q4: 502,077 shares; 2026Q1: 502,077 shares; 2026Q2: 502,077 shares 502,077 $12.7M 0.62% 0 Timeline ARDX ARDELYX INC More: the full row for ARDELYX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 1,463,629 shares; 2025Q1: 1,604,975 shares; 2025Q2: 2,286,273 shares; 2025Q3: 2,286,273 shares; 2025Q4: 2,299,473 shares; 2026Q1: 2,299,473 shares; 2026Q2: 2,241,769 shares 2,241,769 $11.4M 0.56% -57,704 Timeline INSP INSPIRE MED SYS INC More: the full row for INSPIRE MED SYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 130,000 shares; 2024Q4: 130,000 shares; 2025Q1: 99,250 shares; 2025Q2: 107,500 shares; 2025Q3: 110,500 shares; 2025Q4: 131,000 shares; 2026Q1: 131,800 shares; 2026Q2: 244,000 shares 244,000 $10.9M 0.53% +112,200 Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 85,000 shares; 2025Q4: 103,500 shares; 2026Q1: 128,250 shares; 2026Q2: 144,750 shares 144,750 $10.8M 0.53% +16,500 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 106,537 shares; 2025Q4: 139,228 shares; 2026Q1: 183,986 shares; 2026Q2: 199,811 shares 199,811 $10.5M 0.51% +15,825 Timeline SMMT SUMMIT THERAPEUTICS INC More: the full row for SUMMIT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,040,000 shares; 2024Q4: 1,054,000 shares; 2025Q1: 995,000 shares; 2025Q2: 710,000 shares; 2025Q3: 710,000 shares; 2025Q4: 710,000 shares; 2026Q1: 710,000 shares; 2026Q2: 715,000 shares 715,000 $10.4M 0.51% +5,000 Timeline AZTA AZENTA INC More: the full row for AZENTA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 532,500 shares; 2024Q4: 475,000 shares; 2025Q1: 475,000 shares; 2025Q2: 530,400 shares; 2025Q3: 540,400 shares; 2025Q4: 569,100 shares; 2026Q1: 569,100 shares; 2026Q2: 403,000 shares 403,000 $10.3M 0.5% -166,100 Timeline INDV INDIVIOR PHARMACEUTICALS INC More: the full row for INDIVIOR PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares; 2026Q2: 245,500 shares 245,500 $10.1M 0.49% +45,500 Timeline SYK STRYKER CORPORATION More: the full row for STRYKER CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 14,800 shares; 2026Q2: 29,000 shares 29,000 $9.13M 0.45% +14,200 Timeline AMLX AMYLYX PHARMACEUTICALS INC More: the full row for AMYLYX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 343,228 shares; 2025Q2: 499,764 shares; 2025Q3: 499,764 shares; 2025Q4: 499,764 shares; 2026Q1: 499,764 shares; 2026Q2: 499,764 shares 499,764 $8.98M 0.44% 0 Timeline CAI CARIS LIFE SCIENCES INC More: the full row for CARIS LIFE SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 793,651 shares; 2025Q3: 793,651 shares; 2025Q4: 687,500 shares; 2026Q1: 563,000 shares; 2026Q2: 487,500 shares 487,500 $8.69M 0.42% -75,500 Timeline OMDA OMADA HEALTH INC More: the full row for OMADA HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 919,951 shares; 2025Q3: 919,950 shares; 2025Q4: 740,000 shares; 2026Q1: 541,000 shares; 2026Q2: 373,000 shares 373,000 $8.19M 0.4% -168,000 Timeline CMPX COMPASS THERAPEUTICS INC More: the full row for COMPASS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 5,629,239 shares; 2024Q4: 5,779,575 shares; 2025Q1: 4,962,955 shares; 2025Q2: 4,962,955 shares; 2025Q3: 4,474,702 shares; 2025Q4: 3,927,202 shares; 2026Q1: 3,305,308 shares; 2026Q2: 3,524,929 shares 3,524,929 $7.72M 0.38% +219,621 Timeline IMNM IMMUNOME INC More: the full row for IMMUNOME INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 347,666 shares; 2026Q1: 347,666 shares; 2026Q2: 347,666 shares 347,666 $7.37M 0.36% 0 Timeline FOCL EDAP TMS S A More: the full row for EDAP TMS S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,568,000 shares; 2024Q4: 1,591,800 shares; 2025Q1: 1,270,000 shares; 2025Q2: 1,270,000 shares; 2025Q3: 1,270,000 shares; 2025Q4: 1,286,500 shares; 2026Q1: 1,378,000 shares; 2026Q2: 1,386,000 shares 1,386,000 $7.18M 0.35% +8,000 Timeline PHR PHREESIA INC More: the full row for PHREESIA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,282,500 shares; 2024Q4: 2,040,000 shares; 2025Q1: 1,148,336 shares; 2025Q2: 837,300 shares; 2025Q3: 749,116 shares; 2025Q4: 876,600 shares; 2026Q1: 600,400 shares; 2026Q2: 696,900 shares 696,900 $7.17M 0.35% +96,500 Timeline OMER OMEROS CORP More: the full row for OMEROS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 718,499 shares 718,499 $6.83M 0.33% new Timeline DFTX DEFINIUM THERAPEUTICS INC More: the full row for DEFINIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 143,187 shares 143,187 $6.74M 0.33% new Timeline CORT CORCEPT THERAPEUTICS INC More: the full row for CORCEPT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,250 shares; 2026Q1: 50,250 shares; 2026Q2: 72,000 shares 72,000 $6.26M 0.31% +21,750 Timeline JANX JANUX THERAPEUTICS INC More: the full row for JANUX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 204,466 shares; 2025Q1: 204,466 shares; 2025Q2: 210,266 shares; 2025Q3: 210,366 shares; 2025Q4: 358,798 shares; 2026Q1: 367,009 shares; 2026Q2: 367,009 shares 367,009 $5.64M 0.28% 0 Timeline MOBI MOBIA MED INC More: the full row for MOBIA MED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 418,200 shares 418,200 $5.6M 0.27% new Timeline RCUS ARCUS BIOSCIENCES INC More: the full row for ARCUS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 180,000 shares; 2026Q1: 180,000 shares; 2026Q2: 180,000 shares 180,000 $5.55M 0.27% 0 Timeline TMO THERMO FISHER SCIENTIFIC INC More: the full row for THERMO FISHER SCIENTIFIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares; 2026Q2: 10,000 shares 10,000 $5.01M 0.24% 0 Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 260,000 shares 260,000 $4.85M 0.24% new Timeline SION SIONNA THERAPEUTICS INC More: the full row for SIONNA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 99,429 shares; 2025Q2: 99,429 shares; 2025Q3: 99,429 shares; 2025Q4: 99,429 shares; 2026Q1: 99,429 shares; 2026Q2: 99,429 shares 99,429 $4.37M 0.21% 0 Timeline CVS CVS HEALTH CORP More: the full row for CVS HEALTH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,000 shares; 2026Q2: 40,000 shares 40,000 $4.14M 0.2% 0 Timeline EYPT EYEPOINT INC More: the full row for EYEPOINT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 31,655 shares; 2025Q4: 258,739 shares; 2026Q1: 258,739 shares; 2026Q2: 268,519 shares 268,519 $3.84M 0.19% +9,780 Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 345,820 shares; 2026Q1: 383,716 shares; 2026Q2: 383,716 shares 383,716 $3.77M 0.18% 0 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 42,254 shares 42,254 $3.75M 0.18% new Timeline TLPH TALPHERA INC More: the full row for TALPHERA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 316,460 shares; 2024Q4: 316,460 shares; 2025Q1: 316,460 shares; 2025Q2: 316,460 shares; 2025Q3: 3,589,186 shares; 2025Q4: 3,589,186 shares; 2026Q1: 3,589,186 shares; 2026Q2: 3,589,186 shares 3,589,186 $3.7M 0.18% 0 Timeline ROIV ROIVANT SCIENCES LTD More: the full row for ROIVANT SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 88,750 shares; 2026Q1: 97,000 shares; 2026Q2: 101,000 shares 101,000 $3.57M 0.17% +4,000 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 11,100 shares; 2025Q3: 11,100 shares; 2025Q4: 47,000 shares; 2026Q1: 60,250 shares; 2026Q2: 60,250 shares 60,250 $3.5M 0.17% 0 Timeline NGNE NEUROGENE INC More: the full row for NEUROGENE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 95,407 shares; 2025Q1: 104,339 shares; 2025Q2: 104,339 shares; 2025Q3: 104,339 shares; 2025Q4: 104,339 shares; 2026Q1: 104,339 shares; 2026Q2: 106,750 shares 106,750 $3.36M 0.16% +2,411 Timeline IPSC CENTURY THERAPEUTICS INC More: the full row for CENTURY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,304,347 shares; 2026Q2: 1,304,347 shares 1,304,347 $3.2M 0.16% 0 Timeline ATEC ALPHATEC HLDGS INC More: the full row for ALPHATEC HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 200,000 shares; 2025Q1: 267,500 shares; 2025Q2: 267,500 shares; 2025Q3: 302,500 shares; 2025Q4: 302,500 shares; 2026Q1: 350,000 shares; 2026Q2: 360,000 shares 360,000 $3.11M 0.15% +10,000 Timeline NVO NOVO-NORDISK A S More: the full row for NOVO-NORDISK A S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 132,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 90,000 shares; 2026Q2: 63,500 shares 63,500 $3.04M 0.15% -26,500 Timeline OLMA OLEMA PHARMACEUTICALS INC More: the full row for OLEMA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 98,240 shares; 2026Q1: 170,378 shares; 2026Q2: 235,178 shares 235,178 $2.94M 0.14% +64,800 Timeline NGEN NERVGEN PHARMA CORP More: the full row for NERVGEN PHARMA CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,208,231 shares 1,208,231 $2.49M 0.12% new Timeline MDT MEDTRONIC PLC More: the full row for MEDTRONIC PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 30,900 shares 30,900 $2.42M 0.12% new Timeline TEVA TEVA PHARMACEUTICAL INDS LTD More: the full row for TEVA PHARMACEUTICAL INDS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,500 shares; 2026Q1: 45,500 shares; 2026Q2: 59,000 shares 59,000 $2M 0.1% +13,500 Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 26,757 shares; 2026Q2: 20,326 shares 20,326 $1.98M 0.1% -6,431 Timeline SGMT SAGIMET BIOSCIENCES INC More: the full row for SAGIMET BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 787,808 shares; 2024Q4: 787,808 shares; 2025Q1: 787,808 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 250,000 shares 250,000 $1.93M 0.09% new Timeline CAPR CAPRICOR THERAPEUTICS INC More: the full row for CAPRICOR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 74,448 shares 74,448 $1.79M 0.09% new Timeline LENZ LENZ THERAPEUTICS INC More: the full row for LENZ THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 29,305 shares; 2025Q1: 83,082 shares; 2025Q2: 83,982 shares; 2025Q3: 236,227 shares; 2025Q4: 257,460 shares; 2026Q1: 257,460 shares; 2026Q2: 257,460 shares 257,460 $1.46M 0.07% 0 Timeline ALT ALTIMMUNE INC More: the full row for ALTIMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 471,465 shares 471,465 $1.43M 0.07% new Timeline KLRA KAILERA THERAPEUTICS INC More: the full row for KAILERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 65,000 shares 65,000 $1.43M 0.07% new Timeline SGRY SURGERY PARTNERS INC More: the full row for SURGERY PARTNERS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 310,000 shares; 2026Q1: 208,000 shares; 2026Q2: 84,000 shares 84,000 $1.41M 0.07% -124,000 Timeline AXSM AXSOME THERAPEUTICS INC. More: the full row for AXSOME THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,500 shares 5,500 $1.35M 0.07% new Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,123 shares; 2026Q2: 12,051 shares 12,051 $1.15M 0.06% +7,928 Timeline VKTX VIKING THERAPEUTICS INC More: the full row for VIKING THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 96,000 shares; 2026Q2: 25,500 shares 25,500 $995K 0.05% -70,500 Timeline LEGN LEGEND BIOTECH CORP More: the full row for LEGEND BIOTECH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 508,932 shares; 2024Q4: 512,132 shares; 2025Q1: 512,932 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 33,800 shares; 2026Q1: 40,500 shares; 2026Q2: 33,500 shares 33,500 $967K 0.05% -7,000 Timeline GKOS GLAUKOS CORP More: the full row for GLAUKOS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,750 shares 4,750 $664K 0.03% new Timeline JSPR JASPER THERAPEUTICS INC More: the full row for JASPER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 459,088 shares; 2024Q4: 463,088 shares; 2025Q1: 545,171 shares; 2025Q2: 545,171 shares; 2025Q3: 1,100,726 shares; 2025Q4: 1,100,726 shares; 2026Q1: 1,100,726 shares; 2026Q2: 1,100,726 shares 1,100,726 $463K 0.02% 0 Timeline BCRX BIOCRYST PHARMACEUTICALS INC More: the full row for BIOCRYST PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,622,358 shares; 2024Q4: 2,677,996 shares; 2025Q1: 222,011 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 12,600 shares; 2026Q2: 22,124 shares 22,124 $221K 0.01% +9,524 Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 28,200 shares; 2025Q4: 61,700 shares; 2026Q1: 61,700 shares; 2026Q2: 10,696 shares 10,696 $208K 0.01% -51,004 Timeline